Veeva (VEEV) Systems announced that Boehringer Ingelheim is the latest global top 20 biopharma company to commit to moving to Veeva Vault CRM. Boehringer Ingelheim is seeking to expand on its existing Veeva Commercial Cloud solutions and its One Medicine and Amplify platforms, which connect development processes and data on Veeva Development Cloud.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on VEEV:
- Veeva price target raised to $275 from $274 at Baird
- Veeva price target raised to $275 from $250 at RBC Capital
- Veeva price target raised to $280 from $230 at Piper Sandler
- Veeva price target raised to $260 from $240 at Barclays
- Veeva to hold virtual investor day
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
